10x Genomics (TXG) Stock Price, Quote, News & History | Benzinga

SPY779.93+0.11%QQQ759.88+0.03%BTC/USD85,486.60−0.31%DIA514.84+0.05%GLD381.70−0.15%TLT77.26−0.03%

10x Genomics Inc (TXG) Stock Price, Quote, News & History

TXGNASDAQ

Trade with Public

Trade with Public

$80.66

-17.08-17.47%

Last update: Oct 6, 6:46 PM

$80.70

-17.04-17.43%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$100.33

Close

$80.66

Volume / Avg.

9.05M / 3.03M

Day Range

$79.90 - $102.81

52 Wk Range

11.16 - 98.32

Market Cap

$10.51B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

18.79%

Days to Cover

7.09

Recent 10x Genomics, Inc. News

Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.

Chandrima Sanyal

10 Stocks Rally as Rate Hike Bets Collapse on Weak September Jobs

Entegris, Rocket and KLA led premarket gains after September payrolls rose just 29,000 vs. 90,000 expected, cutting bets on a Fed rate hike.

Piero Cingari

This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts initiate coverage: Buy on IonQ ($60), Jack Henry ($193) and 10X Genomics ($110); Overweight Lexicon ($8); In-Line Fortive ($60).

Avi Kapoor

Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.

Chandrima Sanyal

Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday

U.S. stocks fell, but Radiant Logistics surged 17.8% after beating Q4 estimates. Waystar, Telix and Forgent also posted strong gains.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

127.09M

Investing Cash Flow (TTM)

-19.65M

Financing Cash Flow (TTM)

-2.54M

Free Cash Flow (TTM)

121.44M

Capital Expenditure (TTM)

-5.65M

Net Change in Cash (TTM)

104.89M

Analyst Trends and Forecast

1

Jun

1

4

Jul

2

3

Aug

1

3

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$12.26B

PE Ratio (TTM)

-

PE Ratio (FWD)

10000.00

PEG Ratio (TTM)

-

PS Ratio (TTM)

20.23

PB Ratio (TTM)

15.43

Earnings Yield % (TTM)

-0.61%

Earnings Yield % (FWD)

0.01%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

102.77

Book Value / Share

$6.34

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$502.51M

Debt to Equity

0.10

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-